Clear emphasis on generics as Philippines pursues universal care goals
This article was originally published in Scrip
The government of the Philippines has declared medicines to be "a fundamental component" of its plan to overhaul the healthcare scheme to provide universal coverage, with the major caveat that it is generics rather than original branded drugs that are seen playing this central role.
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Plus deals involving LegoChem/Pyxix, Biohaven/Sosei Heptares, Kyowa Kirin/Helsinn, Dr. Reddy’s/Glenmark, Eisai/Wren, KoBioLabs/Kolmar Korea, Y-Biologics/Pierre Fabre, Generex/Chinese consortium.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.